Advanced search
Publication Cover
Current Medical Research and Opinion Volume 26, 2010 - Issue 10
Submit an article Journal homepage
346
Views
22
CrossRef citations to date
0
Altmetric
Original Article

Effect of increasing doses of Rosuvastatin and Atorvastatin on apolipoproteins, enzymes and lipid transfer proteins involved in lipoprotein metabolism and inflammatory parameters

Ioannis K. Karalis Leiden University Medical Center, Leiden, The Netherlands
,
Sandrin C. Bergheanu Leiden University Medical Center, Leiden, The Netherlands
,
Ron Wolterbeek Leiden University Medical Center, Leiden, The Netherlands
,
Geesje M. Dallinga-Thie Academic Medical Center, Amsterdam, The Netherlands
,
Hiroaki Hattori BML Inc., Saitama, Japan
,
Arie van Tol Erasmus University Medical Center, Rotterdam, The Netherlands
,
Anho H. Liem Oosterschelde Hospital, Goes, The Netherlands
&
J. Wouter Jukema Durrer Center for Cardiogenetic Research, Amsterdam, The Netherlands; Leiden University Medical Center, Leiden, The NetherlandsCorrespondence[email protected]
 show all
Pages 2301-2313 | Accepted 15 Jul 2010, Published online: 23 Aug 2010

Citations (22)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (4)

Pornpen Srisawasdi, Punyanuch Rodcharoen, Somlak Vanavanan, Anchalee Chittamma, Chonlaphat Sukasem, Chalitpon Na nakorn, Charungthai Dejthevaporn & Martin H Kroll. (2021) Association of CETP Gene Variants with Atherogenic Dyslipidemia Among Thai Patients Treated with Statin. Pharmacogenomics and Personalized Medicine 14, pages 1-13.
Read now
Ken Kishida, Tohru Funahashi & Iichiro Shimomura. (2013) Effects of pitavastatin on HDL metabolism. Clinical Lipidology 8:1, pages 55-68.
Read now
Aris P Agouridis, Vasilis Tsimihodimos, Theodosios D Filippatos, Andromachi A Dimitriou, Costantinos C Tellis, Moses S Elisaf, Dimitri P Mikhailidis & Alexandros D Tselepis. (2011) The effects of rosuvastatin alone or in combination with fenofibrate or omega 3 fatty acids on inflammation and oxidative stress in patients with mixed dyslipidemia. Expert Opinion on Pharmacotherapy 12:17, pages 2605-2611.
Read now
Eiji Kutoh. (2011) Differential Regulations of Lipid Profiles between Japanese Responders and Nonresponders Treated with Pioglitazone. Postgraduate Medicine 123:1, pages 45-52.
Read now

Articles from other publishers (18)

Mathijs C. Bodde, Paul Welsh, Sandrin C. Bergheanu, Willem M. Lijfering, Bart Mertens, An-Ho Liem, Arnoud van der Laarse, Naveed Sattar & J. Wouter Jukema. (2018) A Rapid (Differential) Effect of Rosuvastatin and Atorvastatin on High-Sensitivity Cardiac Troponin-I in Subjects With Stable Cardiovascular Disease. Clinical Pharmacology & Therapeutics 104:2, pages 311-316.
Crossref
M. John Chapman, Alexina Orsoni, Paul Robillard, Patrice Therond & Philippe Giral. (2018) Duality of statin action on lipoprotein subpopulations in the mixed dyslipidemia of metabolic syndrome: Quantity vs quality over time and implication of CETP. Journal of Clinical Lipidology 12:3, pages 784-800.e4.
Crossref
Vesa M. Olkkonen, Juha Sinisalo & Matti Jauhiainen. (2018) New medications targeting triglyceride-rich lipoproteins: Can inhibition of ANGPTL3 or apoC-III reduce the residual cardiovascular risk?. Atherosclerosis 272, pages 27-32.
Crossref
Fumiyuki Otsuka, XiaoQing Zhao, Hugh H. Trout, Ye Qiao, Bruce A. Wasserman, Masataka Nakano, Colin H. Macphee, Martin Brandt, Sue Krug-Gourley, Liang Guo, Elena R. Ladich, Qi Cheng, Harry R. Davis, Aloke V. Finn, Renu Virmani & Frank D. Kolodgie. (2017) Community-based statins and advanced carotid plaque: Role of CD163 positive macrophages in lipoprotein-associated phospholipase A2 activity in atherosclerotic plaque. Atherosclerosis 267, pages 78-89.
Crossref
Yu Qin, Li Ran, Jing Wang, Li Yu, He-Dong Lang, Xiao-Lan Wang, Man-Tian Mi & Jun-Dong Zhu. (2017) Capsaicin Supplementation Improved Risk Factors of Coronary Heart Disease in Individuals with Low HDL-C Levels. Nutrients 9:9, pages 1037.
Crossref
Marja-Riitta Taskinen & Jan Borén. (2016) Why Is Apolipoprotein CIII Emerging as a Novel Therapeutic Target to Reduce the Burden of Cardiovascular Disease?. Current Atherosclerosis Reports 18:10.
Crossref
Qian Ma, Yujie Zhou, Guangyao Zhai, Fei Gao, Linlin Zhang, Jianlong Wang, Qing Yang & Wanjun Cheng. (2015) Meta-Analysis Comparing Rosuvastatin and Atorvastatin in Reducing Concentration of C-Reactive Protein in Patients With Hyperlipidemia. Angiology 67:6, pages 526-535.
Crossref
Stephen P Adams, Michael Tsang & James M Wright. (2015) Atorvastatin for lowering lipids. Cochrane Database of Systematic Reviews 2017:1.
Crossref
Stephen P Adams, Sarpreet S Sekhon & James M Wright. (2014) Rosuvastatin for lowering lipids. Cochrane Database of Systematic Reviews 2017:1.
Crossref
Benoit J. Arsenault & S. Matthijs Boekholdt. (2013) Clinical and Biological Relevance of Statin-Mediated Changes in HDL Metabolism. Current Atherosclerosis Reports 16:1.
Crossref
Stefania Lamon-Fava. (2013) Statins and lipid metabolism. Current Opinion in Lipidology 24:3, pages 221-226.
Crossref
Stephen P Adams, Michael Tsang & James M Wright. 1996. Cochrane Database of Systematic Reviews. Cochrane Database of Systematic Reviews.
John Gregson, Heide A. Stirnadel-Farrant, Indraraj Umesh Doobaree & Carol Koro. (2012) Variation of lipoprotein associated phospholipase A2 across demographic characteristics and cardiovascular risk factors: A systematic review of the literature. Atherosclerosis 225:1, pages 11-21.
Crossref
Alexander Constantinides, Rindert de Vries, Jeroen J.J. van Leeuwen, Thomas Gautier, L. Joost van Pelt, Alexandros D. Tselepis, Laurent Lagrost & Robin P.F. Dullaart. (2012) Simvastatin but not bezafibrate decreases plasma lipoprotein-associated phospholipase A2 mass in type 2 diabetes mellitus: Relevance of high sensitive C-reactive protein, lipoprotein profile and low-density lipoprotein (LDL) electronegativity. European Journal of Internal Medicine 23:7, pages 633-638.
Crossref
Hisato Takagi & Takuya Umemoto. (2012) A meta-analysis of randomized head-to-head trials of atorvastatin versus rosuvastatin for reductions in C-reactive protein. International Journal of Cardiology 154:1, pages 78-81.
Crossref
Anatol Kontush & M. John Chapman. 2011. High‐Density Lipoproteins. High‐Density Lipoproteins 423 523 .
. (2011) Current World Literature. Current Opinion in Lipidology 22:4, pages 308-310.
Crossref
. (2011) Current World Literature. Current Opinion in Lipidology 22:3, pages 231-236.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.